Cargando…
Upregulated lncRNA CASC9 Contributes to Progression of Non-Small Cell Lung Cancer Through Inhibition of miR-335-3p and Activation S100A14 Expression
INTRODUCTION: Non-small cell lung cancer (NSCLC) is a deadly cancer type worldwide and the main sub-type of lung cancer. Cancer susceptibility candidate-9 (CASC9) was reported to be a key player in cancer progression. However, its function and underlying mechanism in NSCLC remain unclear. MATERIALS...
Autores principales: | Zhao, Weigang, Chen, Tangbing, Zhao, Yonghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321690/ https://www.ncbi.nlm.nih.gov/pubmed/32606808 http://dx.doi.org/10.2147/OTT.S249973 |
Ejemplares similares
-
LncRNA CASC15 is Upregulated in Osteosarcoma Plasma Exosomes and CASC15 Knockdown Inhibits Osteosarcoma Progression by Regulating miR-338-3p/RAB14 Axis
por: Zhang, Hongliang, et al.
Publicado: (2020) -
LncRNA CASC 2 is upregulated in aphthous stomatitis and predicts the recurrence
por: Lu, Jiaping, et al.
Publicado: (2020) -
LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu, Haotao, et al.
Publicado: (2019) -
lncRNA CASC9 sponges miR-758-3p to promote proliferation and EMT in bladder cancer by upregulating TGF-β2
por: Zhang, Zeng, et al.
Publicado: (2021) -
Changes and Prognostic Value of lncRNA CASC9 in Patients with Advanced Colon Cancer after Chemotherapy
por: Jiao, Yingwei, et al.
Publicado: (2021)